Exploring how couples cope with breast cancer
Official title: Breast Cancer, Resilience, Quality of Life and Depression in Couples From Diagnosis to 24 Months Later: Prospective Pilot Study
Run by Regina Elena Cancer Institute · NCT06875414 · Data updated 2026-11-12
This study looks at how couples handle the challenges of breast cancer over two years to see what helps them cope and stay strong together.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 40 (estimated) |
| Sponsor | Regina Elena Cancer Institute Academic / other |
| Locations | 1 site (Roma, Rome) |
| Status | Recruiting |
| Started | November 14, 2022 |
| Main results expected | March 15, 2024 |
| Study ends | November 14, 2025 |
| Registry record updated | March 13, 2025 |
| Trial ID | NCT06875414 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged over 18 diagnosed with stage 1, 2, or 3 breast cancer and their partners who have lived together for at least 6 months.
✕Probably not a fit
Patients with cognitive deficits or those unable to comply with study requirements may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the coping strategies of couples when one partner is diagnosed with breast cancer, focusing on their attitudes and resilience over a 24-month period. Participants include women diagnosed with stage 1, 2, or 3 breast cancer and their partners, who will complete questionnaires and participate in focus groups to provide insights into their experiences. The study aims to understand how couples adapt to the stress of illness and the impact on their quality of life.
Why it matters
Potential benefit: If successful, this study could enhance support strategies for couples dealing with breast cancer, improving their overall quality of life.
How similar studies have gone: While studies on couple dynamics in chronic illness exist, this specific focus on breast cancer resilience is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
INCLUSION CRITERIA: * Woman diagnosed with stage 1, 2 or 3 breast cancer * age\> 18 years (patient and partner) * The partner must have lived with the woman for at least 6 months at diagnosis and treatment * Patients under treatment at the radiotherapy clinic * Subjects available and able to answer questionnaires, interviews, and / or participate in focus groups * Informed consent EXCLUSION CRITERIA: Cognitive deficits and / or inability to comply with the provisions of the study
Where it's running
-
IRCCS Regina Elena National Cancer Institute
Roma, Rome, Italy Recruiting
Study contacts
- Study coordinator: Ilaria Farina, MSN
- Email: ilaria.farina@ifo.it
- Phone: 0652666804
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Improved Facial Skin Quality After VYC-12L for Breast Cancer Survivors
This study tests whether intradermal injections of VYC-12L can improve facial skin quality and quality of life in adults who have completed breast cancer treatment.
-
Breast cancer subtypes and outcomes in Colombian women
This study looks back at medical records of women with breast cancer to see how different molecular subtypes relate to survival and recurrence in a single Colombian hospital.
-
Multimodal psychosomatic symptom care for breast cancer: personalized acupuncture care guided by shared decision-making
This study tests whether personalized acupuncture options (manual acupuncture, ear acupuncture, or both) can help women with breast cancer who have anxiety, sleep problems, or fatigue, compared to routine nursing care.
-
Slow Jogging for Breast Cancer Survivors
This study tests whether a 12-week slow jogging program helps sleep quality in women who have completed breast cancer treatment.
-
Methylscape test in body fluids for multi-cancer detection in Colombia
A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.
-
Benchmarking AI language models against tumor boards for oncology treatment decisions
This project tests whether frontier AI language models can match the treatment recommendations of multidisciplinary tumor boards for common cancers using standardized synthetic cases.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.